Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lluís Caral"'
Autor:
Juan José Acebes, Isidro Ferrer, Juan Miguel Gil, Nuria Viñolas, Eugenia Verger, Marta Brell, Salvador Villà, Lluís Caral, Francesc Graus, Avelina Tortosa, Teresa Pujol, Teresa Ribalta
Publikováno v:
Clinical Cancer Research. 11:5167-5174
Purpose: Anaplastic gliomas constitute a heterogeneous group of tumors with different therapeutic responses to adjuvant chemotherapy with alkylating agents. O6-Methylguanine-DNA methyltransferase (MGMT), a DNA repair protein, is one of the implicated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::684d068d9d610b1b7b5ed9a5617ddcb4
https://doi.org/10.1158/1078-0432.ccr-05-0230
https://doi.org/10.1158/1078-0432.ccr-05-0230
Autor:
Isidre Ferrer, Teresa Ribalta, Teresa Pujol, Lluís Caral, Salvador Villà, Eugènia Verger, Francesc Graus, Avelina Tortosa, Juan J. Acebes, Núria Viñolas, Marta Brell, Juan M. Gil
Publikováno v:
Cancer. 97:1063-1071
BACKGROUND The clinical evolution of anaplastic glioma (anaplastic astrocytoma, oligodendroglioma, and oligoastrocytoma) is variable. Previous studies merged patients with anaplastic glioma and the much more common glioblastoma multiforme. Therefore,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6195a23678e9d81b862c8903e54ba4cc
https://doi.org/10.1002/cncr.11120
https://doi.org/10.1002/cncr.11120
Autor:
Jordi Rumià, Jaume Capellades, Laura Oleaga, Teresa Boget, S. Medrano, Teresa Pujol, Sofía González-Ortiz, Núria Bargalló, Lluís Caral
Publikováno v:
AJNR Am J Neuroradiol
Europe PubMed Central
Europe PubMed Central
BACKGROUND AND PURPOSE: Whereas fMRI postprocessing tools used in research are accurate but unwieldy, those used for clinical practice are user-friendly but are less accurate. We aimed to determine whether commercial software for fMRI postprocessing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cef2b33a348f6c42270a02f96f18412a
https://europepmc.org/articles/PMC7964578/
https://europepmc.org/articles/PMC7964578/
Autor:
Laura Oleaga, Eugenia Verger, Lluís Caral, Estela Pineda, Francesc Graus, Teresa Ribalta, I. Valduvieco, Teresa Pujol, Jordi Bruna, Teresa Boget
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 15(4)
Previous studies in glioblastoma have concluded that there is no decrease in survival with increasing time to initiation of RT up to 6 weeks after surgery. Unfortunately, the number of glioblastoma patients who start RT beyond 6 weeks is not small in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0c9004a694909ac02854a620a75efc
https://pubmed.ncbi.nlm.nih.gov/22855197
https://pubmed.ncbi.nlm.nih.gov/22855197
Autor:
Avelina, Tortosa, Núria, Viñolas, Salvador, Villà, Eugènia, Verger, Juan M, Gil, Marta, Brell, Lluís, Caral, Teresa, Pujol, Juan J, Acebes, Teresa, Ribalta, Isidre, Ferrer, Francesc, Graus
Publikováno v:
Cancer. 97(4)
The clinical evolution of anaplastic glioma (anaplastic astrocytoma, oligodendroglioma, and oligoastrocytoma) is variable. Previous studies merged patients with anaplastic glioma and the much more common glioblastoma multiforme. Therefore, the conclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::914fb5570c9372d8a30f4e6520d9224a
https://pubmed.ncbi.nlm.nih.gov/12569607
https://pubmed.ncbi.nlm.nih.gov/12569607
Autor:
Teresa Ribalta, I. Valduvieco, Teresa Pujol, Francesc Graus, Lluís Caral, Laura Oleaga, Eugenia Verger, Estela Pineda, Teresa Boget
Publikováno v:
Radiotherapy and Oncology. 103:S254
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30b30b5b138867df58849258db66a6b6
https://doi.org/10.1016/s0167-8140(12)70983-0
https://doi.org/10.1016/s0167-8140(12)70983-0
Autor:
I. Valduvieco, Teresa Boget, Teresa Ribalta, Eugenia Verger, Francesc Graus, Laura Oleaga, Nuria Viñolas, Yolanda Blanco, Teresa Pujol, Lluís Caral
Publikováno v:
Europe PubMed Central
BACKGROUND The clinical outcome of glioblastoma (GBM) patients who receive radiotherapy alone or with chemotherapy is well established. However, little is known about how many patients do not receive this treatment. We consider it is important to inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d42f46085afca100c14498856eecfac0
http://europepmc.org/abstract/med/21975336
http://europepmc.org/abstract/med/21975336